Clinical Trial Update: Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 10 micrograms of estradiol vaginal tablets to promestriene vaginal cream for vulvovaginal atrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Atrophy

Drugs mentioned

• Estradiol vaginal tablets (10 micrograms) (estradiol)
• Promestriene vaginal cream (promestriene)

Snippet

Sponsor: Instituto Palacios | Conditions: Vulvovaginal Atrophy | Phase 3 | Status: COMPLETED